Vermont 2023-2024 Regular Session

Vermont House Bill H0777

Introduced
1/12/24  

Caption

An act relating to donor-conceived persons and gamete agencies, gamete banks, and fertility clinics

Impact

The introduction of H0777 will significantly affect state laws regarding the operations of fertility clinics and gamete banks in Vermont. The law would create a comprehensive licensure and regulatory framework governing these entities, including strict penalties for non-compliance, such as the potential revocation of licenses and civil fines. Moreover, it would impose limits on the number of live births from a single donor, thereby addressing concerns about genetic diversity and the well-being of donor-conceived individuals. As a result, facilities would need to enhance their operational protocols to comply with these new regulations, marking a substantial shift in the reproductive health landscape in Vermont.

Summary

House Bill H0777 seeks to establish regulations surrounding gamete agencies, gamete banks, and fertility clinics in Vermont. The purpose of the bill is to ensure a higher standard of care and transparency in assisted reproduction services by requiring these entities to obtain a license from the Vermont Department of Health. The bill mandates facilities to collect and disclose identifying information and medical history of gamete donors, with an emphasis on protecting the interests of donor-conceived persons. This regulation is intended to facilitate better medical care and familial relationships for individuals conceived through donor gametes, especially as they reach adulthood and may seek to understand their origins.

Contention

While the bill aims to safeguard the interests of donor-conceived persons and establish clearer guidelines within reproductive health services, there may be points of contention regarding its requirements. Critics may argue that the regulations could add undue bureaucratic pressure on fertility clinics and gamete agencies, potentially limiting access to reproductive health services in Vermont. Furthermore, there may be privacy concerns raised by gamete donors regarding the disclosure of their personal information, which could affect their willingness to participate in donor programs. The balance between protecting the interests of families and ensuring donor privacy will likely be a critical discussion point as the bill is considered.

Companion Bills

No companion bills found.

Previously Filed As

VT HB482

Health - Donor-Conceived Individuals and Gamete Agencies, Gamete Banks, and Fertility Clinics

VT AB1896

Gamete banks.

VT HB1259

In Vitro Fertilization Protection & Gamete Donation Requirements

VT SB224

Protections For Donor-conceived Persons And Families

VT SB2418

DONOR-CONCEIVED PERSON PROTECT

VT SB223

Licensing for Clinics That Provide Fertility Services

VT H0302

An act relating to health insurance and Medicaid coverage for fertility care

VT H0369

An act relating to health insurance and Medicaid coverage for fertility-related services

VT S0063

An act relating to health insurance and Medicaid coverage for fertility-related services

VT H0055

An act relating to coverage for fertility treatment and gender-affirming health care services

Similar Bills

IL SB1679

HEALTH CARE TRANSPARENCY

IL HB2904

HEALTH CARE TRANSPARENCY

NJ S3493

Requires affirmative written consent for certain entities to disclose individual's medical information regarding reproductive health care services, with limited exceptions, unless disclosure is necessary to provide those services.

NJ A4658

Requires affirmative written consent for certain entities to disclose individual's medical information regarding reproductive health care services, with limited exceptions, unless disclosure is necessary to provide those services.

VT S0074

An act relating to the collection, sharing, and selling of consumer health data

NJ A4314

Expands definition of personal data to include use of reproductive health care services and prohibits collection of reproductive health care prescription drugs from Prescription Monitoring Program.

CA SB574

Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2019.

CA AB254

Confidentiality of Medical Information Act: reproductive or sexual health application information.